Guidance for Puma Biotechnology, Inc. (PBYI)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2026 | N/A | N/A | $214.00M – 221.00M | $220.00M | = Maintained | Details |
| Q2 2026 | N/A | N/A | $52.00M – 55.00M | $52.00M | = Maintained | Details |
| Q1 2026 | N/A | N/A | $38.00M – 42.00M | $49.00M | = Maintained | Details |
| 2025 | N/A | N/A | $212.00M – 222.00M | $220.00M | = Maintained | Details |
| 2025 | N/A | N/A | $192.00M – 198.00M | $218.20M | = Maintained | Details |
| Q3 2025 | N/A | N/A | $48.00M – 51.00M | $57.50M | = Maintained | Details |
| Q2 2025 | N/A | N/A | $48.00M – 50.00M | $52.75M | = Maintained | Details |
| 2024 | N/A | N/A | $183.00M – 190.00M | $217.60M | = Maintained | Details |
| 2023 | N/A | N/A | $206.00M – 209.00M | $236.20M | = Maintained | Details |
| 2023 | N/A | N/A | $205.00M – 210.00M | $231.40M | = Maintained | Details |
| 2023 | N/A | N/A | $205.00M – 210.00M | $227.40M | = Maintained | Details |
| Q3 2023 | N/A | N/A | $51.00M – 53.00M | $51.73M | = Maintained | Details |
| Q1 2023 | N/A | N/A | $43.00M – 46.00M | $51.00M | = Maintained | Details |
| Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
